top of page

Trvalý pobyt v Kolumbii

Verejný·4 členovia

Accelrys Discovery Studio 25 Crack

Accelrys Discovery Studio 25: A Powerful Tool for Drug Discovery

Drug discovery is a complex and challenging process that requires the integration of multiple disciplines, such as chemistry, biology, pharmacology, and informatics. To facilitate this process, researchers need advanced computational tools that can help them design, model, simulate, and analyze potential drug candidates and their interactions with biological targets. One such tool is Accelrys Discovery Studio 25 (DS 25), a suite of software applications for simulating small molecule and macromolecule systems. DS 25 is developed and distributed by Dassault Systemes BIOVIA (formerly Accelrys), a leading provider of scientific innovation lifecycle management solutions. In this article, we will introduce some of the key features and benefits of DS 25 for drug discovery.

What is DS 25?

DS 25 is a comprehensive and integrated software environment that covers various aspects of drug discovery, such as:


  • Simulations: DS 25 offers a range of simulation methods, including molecular mechanics, molecular dynamics, quantum mechanics, hybrid QM/MM, implicit and explicit solvent models, membrane models, and more. These methods allow researchers to study the structure, dynamics, properties, and reactivity of molecules and their complexes at different levels of accuracy and complexity.

  • Ligand Design: DS 25 provides tools for designing and optimizing small molecules for drug discovery. These include tools for enumerating molecular libraries, generating pharmacophore models, performing virtual screening, applying fragment-based design, docking ligands to receptors, refining poses, and performing de novo design.

  • Macromolecule Design and Validation: DS 25 supports the design and analysis of macromolecules, such as proteins, nucleic acids, carbohydrates, and lipids. These include tools for macromolecule engineering, protein-protein docking, antibody design and optimization, membrane-bound protein analysis, GPCR modeling, homology modeling, loop modeling, structure validation, and more.

  • QSAR: DS 25 enables the development and application of quantitative structure-activity relationship (QSAR) models for predicting the biological activity of molecules based on their structural features. These include methods such as multiple linear regression, partial least squares, recursive partitioning, genetic function approximation, and 3D field-based QSAR.

  • ADME: DS 25 helps researchers to evaluate the absorption, distribution, metabolism, excretion (ADME) properties of molecules and their potential toxicity. These include tools for predicting solubility, permeability, lipophilicity, plasma protein binding, blood-brain barrier penetration, cytochrome P450 inhibition and induction, mutagenicity, carcinogenicity, hepatotoxicity, cardiotoxicity, and more.

DS 25 is built upon Pipeline Pilot, a scientific operating platform that allows researchers to integrate any tool they need to create customized workflows and solutions. Pipeline Pilot also enables the deployment and sharing of these workflows within a group or across an organization via web portals or Microsoft SharePoint. This enhances collaboration and productivity among researchers and facilitates decision making in drug discovery.

What are the benefits of DS 25?

DS 25 offers several benefits for drug discovery researchers:

Scientific Excellence: DS 25 incorporates state-of-the-art scientific algorithms and methods that have been developed by leading experts in the field. Some of these methods have been originally developed in the academic community and have been validated by extensive publications. For example,

  • CHARMM is a widely used molecular mechanics program for biomolecular simulations.

  • MODELLER is a popular program for protein homology modeling.

  • DELPHI is a powerful method for solving the Poisson-Boltzmann equation for electrostatic calculations.

  • ZDOCK is a fast and accurate protein-protein docking algorithm.

  • DMol3 is a quantum mechanics program for studying molecular systems.

  • User Experience: DS 25 provides a user-friendly interface that can be fully customized to suit the preferences and needs of different users. Users can create their own Discovery Guides, which are personalized taskflows that combine any scientific algorithm and/or functionality in DS 25. Users can also access and modify the existing Discovery Guides that are provided by DS 25 for common tasks, such as ligand docking, pharmacophore modeling, protein-protein docking, etc. Users can also leverage the integration with Pipeline Pilot to access and use additional scientific components and protocols that are not available in DS 25.

  • Collaboration and Communication: DS 25 facilitates collaboration and communication among researchers by allowing them to share and reuse their workflows, data, and results. Users can easily export and import their Discovery Guides, data sets, and reports in various formats. Users can also publish their workflows and results to web portals or Microsoft SharePoint, where they can be accessed and viewed by other users. Users can also annotate and comment on their workflows and results to provide feedback and suggestions.


DS 25 is a powerful and versatile tool for drug discovery that offers a comprehensive suite of software applications for simulating, designing, and analyzing small molecule and macromolecule systems. DS 25 is based on the Pipeline Pilot platform, which enables the integration, customization, and deployment of scientific workflows and solutions. DS 25 also enhances user experience, collaboration, and communication among researchers. DS 25 is a valuable asset for any drug discovery researcher who wants to accelerate their research process and achieve better outcomes.


  • Pipeline Pilot

  • Discovery Studio 2.5





  • DMol3

  • DMol3

  • Informácie

    Táto skupina je zameraná na Slovákov a Čechov, ktorí majú tr...

    {počet, množné číslo, iné {členovia}}

    bottom of page